BUSINESS BRIEF
Company represents a fast-growing Oncology API manufacturer, recently acquired by a diversified pharmaceutical group with interests across formulations, distribution, retail, and exports. The company operates a world-class API facility in Maharashtra, India, compliant with ISO, GMP, and ICH standards, catering to regulated and semi-regulated markets.
Business Divisions
Yes, business has diferent verticals this is the subsidary for the group level company.
Products & Services
Details in Deck
Proposal
Industry
Pharmaceuticals
Sub Industry
Pharmaceutical Manufacturing (Bulk Drug & API), Pharmaceutical Manufacturing (Formulation), Pharmaceutical Manufacturing (Over-the-Counter (OTC)), Pharmaceutical Services (Distributor), Pharmaceutical Services (CDMO/CRAMS) & Pharmaceutical Services (Life Sciences Research and Development)
Nature of Business
B2B
Sector
Lifesciences
Location
India
Region
Western
Open For Dilution
12 %
Top Customer
Ask
INR 5 Cr
End use of fund
For Expansion and Growth
Business Operation Information
Financial Information |
2025 (in INR Cr) | 2024 (in INR Cr) | 2023 (in INR Cr) |
|---|---|---|---|
Sales |
5.7 | 7.13 | 0.6 |
EBITDA |
|||
PAT |
